IXICO (LON:IXI) Share Price Passes Below Two Hundred Day Moving Average – Time to Sell?

IXICO plc (LON:IXI)’s share price passed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of GBX 8.57 and traded as low as GBX 8. IXICO shares last traded at GBX 8, with a volume of 6,847 shares traded.

IXICO Stock Down 5.9%

The company has a market cap of £17.52 million, a P/E ratio of -4.10, a price-to-earnings-growth ratio of -0.38 and a beta of 0.13. The company has a 50 day moving average of GBX 8.41 and a 200-day moving average of GBX 8.57. The company has a debt-to-equity ratio of 5.22, a current ratio of 2.83 and a quick ratio of 4.90.

IXICO (LON:IXI) last released its quarterly earnings results on Tuesday, May 19th. The company reported GBX (1.21) earnings per share for the quarter. The business had revenue of GBX 395 million during the quarter. IXICO had a negative net margin of 24.98% and a negative return on equity of 16.18%. On average, equities analysts predict that IXICO plc will post -289.3584879 earnings per share for the current year.

Insider Buying and Selling at IXICO

In related news, insider Mark Warne acquired 50,006 shares of the stock in a transaction dated Wednesday, July 15th. The shares were purchased at an average price of GBX 8 per share, for a total transaction of £4,000.48. Company insiders own 3.05% of the company’s stock.

IXICO Company Profile

IXICO is a global leader in neuroscience imaging and biomarker analytics, using its proprietary AI-driven platform to help advance the treatment of neurological disorders and reduce the uncertainties associated with drug discovery, development and monitoring.

By unlocking valuable insights into drug safety and efficacy, IXICO has built a global reputation and 20-year track record as an end-to-end Imaging Contract Research Organisation (iCRO) managing and analysing neurological clinical trials.